NCT00435968View on ClinicalTrials.gov

Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

July 31, 2007

Conditions

Healthy

Interventions

DRUG

CVT E002 (Cold-fX)

Trial Locations (1)

07601

Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

CV Technologies

All Listed Sponsors

lead

CV Technologies

INDUSTRY

NCT00435968 - Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults | Biotech Hunter | Biotech Hunter